Michael G Grey

Director; Director, Executive Chairman · 4 filings · Latest: Aug 7, 2026

Mirum Pharmaceuticals, Inc.

OnKure Therapeutics, Inc.

SPRUCE BIOSCIENCES, INC.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
MIRM	MICHAEL GREY	—	Dec 19, 2025	Proposed Sale	$78.00	50,000	$3.9M	—	Dec 19 9:05 PM
MIRM	MICHAEL GREY	—	Dec 1, 2025	Proposed Sale	$74.00	50,000	$3.7M	—	Dec 1 9:07 PM
MIRM	MICHAEL GREY	—	Nov 21, 2025	Proposed Sale	$70.00	50,000	$3.5M	—	Nov 21 9:09 PM